相关实验视频

Updated: Jul 13, 2025

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

GPER:在转移和瘤微环境中的雌激素受体关键

Ana Carolina Tirado-Garibay¹, Elba Andrea Falcón-Ruiz¹, Alejandra Ochoa-Zarzosa¹

¹Centro Multidisciplinario de Estudios en Biotecnología-FMVZ, Universidad Michoacana de San Nicolás de Hidalgo, Morelia 58893, Mexico.

International journal of molecular sciences

|October 14, 2023

概括

与G蛋白结合的雌激素受体 (GPER) 在癌症进展中起着关键作用,特别是在上皮-介质细胞过渡 (EMT) 和转移中. GPER代表了癌症治疗的潜在治疗标.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
内分泌学在内分泌学.

背景情况:

雌激素信号传递在癌症中至关重要,一些癌症通过雌激素反应来分类.
一种与G蛋白结合的雌激素受体 (GPER) 已经在癌症生物学中显著出现.
在癌细胞中,GPER表现出特定于组织的活性,影响正常发育和平衡,但可以在癌细胞中表现出支持或反对瘤的作用.

研究的目的:

审查GPER在上细胞-介质细胞过渡 (EMT) 在瘤原生细胞和相关细胞中的作用.
要突出GPER在癌症的主要特征方面的参与.
探索针对癌症GPER的潜在治疗策略.

主要方法:

文献综述侧重于GPER在癌症中的功能.
分析GPER在上皮层-介质细胞过渡 (EMT) 中的作用.
检查GPER与癌症特征和治疗潜力的关系.

主要成果:

GPER影响表皮层-介质细胞过渡 (EMT),这是癌症转移的关键过程.
在瘤微环境中存在GPER,有助于瘤的传播和维护.
在缺乏雌激素受体α (ERα) 的癌细胞中,GPER可以调节雌激素反应.

结论:

GPER与关键的癌症过程有关,包括EMT和转移.
该受体在瘤微环境可塑性中的作用表明它在癌症进展中的重要性.
现在,GPER成为调节癌症发展和治疗的有前途的治疗点.

关键词:

一个GPER的医生.表皮 mesenchymal 过渡期间的表皮.转移转移转移转移治疗目标是治疗的目标.瘤微环境是一个微环境.

更多相关视频

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...